Butzelaar R M, Fortner J G
Neth J Surg. 1981 May;33(2):79-82.
From a series of 89 patients treated with hemipelvectomy at the Memorial Sloan-Kettering Cancer Center during the period 1972--1976, 16 patients with soft tissue sarcoma are discussed. Three patients were operated on for palliative reasons. Most of the remaining 13 patients underwent a hemipelvectomy after other more conservative procedures had failed to control the disease. Mortality rate was zero; the morbidity 50%, but all complications responded to conservative treatment except for two patients with postoperative hemorrhage. The results are discussed, as is the rehabilitation of the patients. Hemipelvectomy seems to have a place in palliative treatment of patients with soft tissue sarcoma. The one-year cumulative survival rate of 69.2% and the five-year cumulative survival rate of 42.6% appear to justify hemipelvectomy for highly selected patients with soft tissue sarcoma who cannot otherwise be treated successfully.
在纪念斯隆-凯特琳癌症中心1972年至1976年期间接受半骨盆切除术治疗的89例患者中，对16例软组织肉瘤患者进行了讨论。3例患者因姑息性原因接受手术。其余13例患者中的大多数在其他更保守的治疗方法未能控制疾病后接受了半骨盆切除术。死亡率为零；发病率为50%，但除两名术后出血患者外，所有并发症均对保守治疗有反应。本文讨论了结果以及患者的康复情况。半骨盆切除术似乎在软组织肉瘤患者的姑息治疗中占有一席之地。69.2%的一年累积生存率和42.6%的五年累积生存率似乎证明，对于其他方法无法成功治疗的经过严格筛选的软组织肉瘤患者，半骨盆切除术是合理的。
